Tag: Beam Therapeutics
Beam Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference
CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through...
Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors...
Data Published in The CRISPR Journal Describe Inlaid Base Editors (IBEs) that Enhance Editing Efficiency and Capability, an Advancement of the Company’s Pioneering...